MFDS
- Status: likely_approved
🇰🇷 Xifaxan in South Korea
Xifaxan (rifaximin) regulatory status in South Korea.
Marketing authorisation
Xifaxan in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Gastroenterology approved in South Korea
Frequently asked questions
Is Xifaxan approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Xifaxan in South Korea?
Bausch Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.